Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 16
Gene Symbol: AARS1
AARS1
0.100 Biomarker phenotype HPO
Entrez Id: 39
Gene Symbol: ACAT2
ACAT2
0.100 Biomarker phenotype HPO
Entrez Id: 51816
Gene Symbol: ADA2
ADA2
0.100 Biomarker phenotype HPO
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.130 Biomarker phenotype HPO
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.130 GeneticVariation phenotype BEFREE Adenylyl cyclase 5 (ADCY5) mutations is associated with heterogenous syndromes: familial dyskinesia and facial myokymia; paroxysmal chorea and dystonia; autosomal-dominant chorea and dystonia; and benign hereditary chorea. 27061943 2016
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.130 Biomarker phenotype BEFREE ADCY5 genetic analysis should be performed in cases with a benign choreiform movement disorder even in the absence of facial myokymia. 26085604 2015
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.130 GeneticVariation phenotype BEFREE Whole exome sequencing in a three-generation family affected with autosomal dominant chorea associated with dystonia identified a single de novo mutation—c.2088+1G>A in a 5' donor splice-site of ADCY5—segregating with the disease. 25545163 2015
Entrez Id: 174
Gene Symbol: AFP
AFP
0.010 Biomarker phenotype BEFREE Four strains demonstrated RDS that was less pronounced than in most AT cells: one was from a patient with Nijmegen breakage syndrome, one was from a patient without ataxia but with choreiform movement disorder, telangiectasia, and elevated concentrations of alpha-fetoprotein in the blood, and two were from AT patients. 2722185 1989
Entrez Id: 9255
Gene Symbol: AIMP1
AIMP1
0.100 Biomarker phenotype HPO
Entrez Id: 79868
Gene Symbol: ALG13
ALG13
0.100 CausalMutation phenotype CLINVAR De novo mutations in epileptic encephalopathies. 23934111 2013
Entrez Id: 54840
Gene Symbol: APTX
APTX
0.010 Biomarker phenotype BEFREE AOA1 is associated with oculomotor apraxia, severe sensorimotor neuropathy, choreiform movements, cognitive impairment, and cerebellar atrophy at an early age. 16700949 2006
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.100 Biomarker phenotype HPO
Entrez Id: 4508
Gene Symbol: ATP6
ATP6
0.100 Biomarker phenotype HPO
Entrez Id: 538
Gene Symbol: ATP7A
ATP7A
0.100 Biomarker phenotype HPO
Entrez Id: 51761
Gene Symbol: ATP8A2
ATP8A2
0.010 GeneticVariation phenotype BEFREE All patients with ATP8A2 mutations (100%) demonstrated developmental delay, severe hypotonia and movement disorders, specifically chorea or choreoathetosis (100%), dystonia (27%) and facial dyskinesia (18%). 30012219 2018
Entrez Id: 6310
Gene Symbol: ATXN1
ATXN1
0.100 Biomarker phenotype HPO
Entrez Id: 25814
Gene Symbol: ATXN10
ATXN10
0.010 Biomarker phenotype BEFREE Twenty-eight patients with SCA1, 11 patients with SCA6, and 3 patients with SCA10 were also evaluated, and none of them presented chorea. 25456461 2014
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.100 Biomarker phenotype HPO
Entrez Id: 4287
Gene Symbol: ATXN3
ATXN3
0.010 GeneticVariation phenotype BEFREE This study demonstrates the use of LV encoding mutant ataxin-3 to produce a model of MJD and brings evidence of striatal pathology, suggesting that this region may contribute to dystonia and chorea observed in some MJD patients and may represent a target for therapies. 18385100 2008
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.100 Biomarker phenotype HPO
Entrez Id: 148789
Gene Symbol: B3GALNT2
B3GALNT2
0.100 Biomarker phenotype HPO
Entrez Id: 57102
Gene Symbol: C12orf4
C12orf4
0.100 Biomarker phenotype HPO
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.110 GeneticVariation phenotype BEFREE In continuation with this observation, we analyzed a small cohort of 39 patients with HD phenocopy syndrome and detected the C9orf72 expansion in one female patient (2.6%) with two-year lasting mild generalized chorea and severe oro-bucco-lingual dyskinesia, who complained on forgetfullness (neuropsychological testing revealed dysexecutive syndrome with preserved episodic memory and recognition), unexplainable fears and increased appetite. 25034271 2014
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.110 Biomarker phenotype HPO
Entrez Id: 773
Gene Symbol: CACNA1A
CACNA1A
0.010 GeneticVariation phenotype BEFREE We excluded linkage to 11 regions containing genes associated with chorea and myokymia: 1) the Huntington disease gene on chromosome 4p; 2) the paroxysmal dystonic choreoathetosis gene at 2q34; 3) the dentatorubral-pallidoluysian atrophy gene at 12p13; 4) the choreoathetosis/spasticity disease locus on 1p that lies in a region containing a cluster of potassium (K+) channel genes; 5) the episodic ataxia type 1 (EA1) locus on 12p that contains the KCNA1 gene and two other voltage-gated K+ channel genes, KCNA5 and KCNA6; 6) the chorea-acanthocytosis locus on 9q21; 7) the Huntington-like syndrome on 20p; 8) the paroxysmal kinesigenic dyskinesia locus on 16p11.2-q11.2; 9) the benign hereditary chorea locus on 14q; 10) the SCA type 5 locus on chromosome 11; and 11) the chromosome 19 region that contains several ion channels and the CACNA1A gene, a brain-specific P/Q-type calcium channel gene associated with ataxia and hemiplegic migraine. 11310626 2001